Secondary erythrocytosis produced by the tyrosine kinase inhibitors sunitinib and sorafenib.
Alexandrescu DT; McClure R; Farzanmehr H; Dasanu CA; Journal Of Clinical Oncology: Official Journal Of The American Society Of Clinical Oncology, 2008, vol. 26, issue 24, p 4047, ISSN 15277755. ISBN 15277755.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef